The Latest in AML

Decitabine produces responses in high-risk MDS, AML

November 29, 2016

EC grants drug orphan status for AML, sarcoma

November 24, 2016

EMA recommends orphan status for drug in AML

November 15, 2016

FDA grants priority review for midostaurin

November 15, 2016

Combating drug resistance in FLT3-mutated AML

November 6, 2016

Team targets fructose to treat AML

November 4, 2016

Targeting CD98 to treat AML

November 3, 2016

Team maps genomic landscape of CBF-AML

November 1, 2016

Compound could treat a range of blood cancers

October 25, 2016

Combo produces CR/CRis in FLT3-ITD AML

October 20, 2016

Work reveals potential therapeutic targets in AML

October 19, 2016

Proteins may be therapeutic targets for AML subtype

October 17, 2016

Combo could treat AML, other cancers

October 14, 2016

‘Practice-changing’ treatments emerging in AML

October 6, 2016

Inflammation may predict transformation to AML

October 5, 2016